Agonistic and Antagonistic Effects of Progesterone Derivatives on the Transcriptional Activity of Nuclear Progesterone Receptor B in Yeast Model System


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Identification of progesterone selective agonists and antagonists that act through one of the nuclear progesterone receptor isoforms is of particular importance for the development of tissue-specific drugs in gynecology and anticancer therapy. Fourteen pregna-D′6- and pregna-D′3-pentarane progesterone derivatives with 16α,17α-cycloalkane groups and two progesterone 3-deoxyderivatives were examined for their ability to regulate transcriptional activity of human nuclear progesterone receptor isoform B (nPR-B) expressed in Saccharomyces cerevisiae yeast. Transcriptional activity of nPR-B was measured from the expression of the β-galactosidase reporter gene with a hormone-responsible element in the promoter. Among the compounds tested, two were full progesterone agonists, four were partial agonists, one compound possessed both agonistic and antagonistic activity, one compound displayed only partial antagonistic activity, and eight compounds did not show any activity. Modifications of the pentarane structure, precisely, introduction of an additional double bound in the A or B rings and/or modification at the 6th position of progesterone, lead to a switch from the complete agonistic activity to partial agonistic or mixed activities. These modifications enable progestins to act as selective modulators of progesterone receptor. Steroids with reduced A-ring and 3-ketogroups lose their ability to regulate PR-B activity. Both 3-deoxycompounds, being selective ligands of progesterone membrane receptors, do not affect PR-B activity.

About the authors

A. O. Michurina

Lomonosov Moscow State University

Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 119899

A. V. Polikarpova

Lomonosov Moscow State University

Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 119899

I. S. Levina

Zelinsky Institute of Organic Chemistry

Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 117913

L. E. Kulikova

Zelinsky Institute of Organic Chemistry

Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 117913

I. V. Zavarzin

Zelinsky Institute of Organic Chemistry

Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 117913

A. A. Guseva

Lomonosov Moscow State University

Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 119899

I. A. Morozov

Engelhardt Institute of Molecular Biology

Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 119991

P. M. Rubtsov

Engelhardt Institute of Molecular Biology

Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 119991

O. V. Smirnova

Lomonosov Moscow State University

Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 119899

T. A. Shchelkunova

Lomonosov Moscow State University

Author for correspondence.
Email: schelkunova-t@mail.ru
Russian Federation, Moscow, 119899


Copyright (c) 2018 Pleiades Publishing, Ltd.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies